- Home
- OFIX
as 02-21-2025 4:00pm EST
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Upcoming Earnings Alert:
Get ready for potential market movements as Orthofix Medical Inc. (DE) OFIX prepares to release earnings report on 25 Feb 2025.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | LEWISVILLE |
| Market Cap: | 722.6M | IPO Year: | N/A |
| Target Price: | $23.33 | AVG Volume (30 days): | 116.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.08 - $20.73 | Next Earning Date: | 02-25-2025 |
| Revenue: | $784,249,000 | Revenue Growth: | 17.32% |
| Revenue Growth (this year): | 8.81% | Revenue Growth (next year): | 6.34% |
Stock Insider Trading Activity of Orthofix Medical Inc. (DE) (OFIX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gillespie Geoffrey C | OFIX | CAO | Feb 3 '25 | Sell | $17.94 | 954 | $17,025.89 | 39,323 | |
| Andrews Julie | OFIX | CFO | Jan 16 '25 | Sell | $17.89 | 4,655 | $83,277.95 | 28,312 | |
| Gillespie Geoffrey C | OFIX | CAO | Jan 10 '25 | Sell | $16.99 | 475 | $8,065.20 | 39,323 | |
| Calafiore Massimo | OFIX | President & CEO | Jan 10 '25 | Sell | $16.99 | 19,281 | $327,375.69 | 124,151 | |
| Gillespie Geoffrey C | OFIX | CAO | Jan 7 '25 | Sell | $17.05 | 476 | $8,117.47 | 39,323 | |
| Gillespie Geoffrey C | OFIX | CAO | Dec 17 '24 | Sell | $17.84 | 26 | $463.84 | 39,323 |
Latest Orthofix Medical Inc. (DE) News
OFIX Breaking Stock News: Dive into OFIX Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference
Business Wire
25 days ago
Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 01/15/2025
MT Newswires
a month ago
Orthofix Medical Insider Sold Shares Worth $327,376, According to a Recent SEC Filing
Simply Wall St.
3 months ago
Orthofix Medical's (NASDAQ:OFIX) investors will be pleased with their decent 76% return over the last year
Business Wire
3 months ago
Orthofix to Participate in Upcoming Investor Conferences
TipRanks
3 months ago
Orthofix Reports Q3 Sales Growth and New Financial Targets
GuruFocus.com
3 months ago
Orthofix Medical Inc (OFIX) Q3 2024 Earnings Call Highlights: Strong Growth in US Spine ...
Compare OFIX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OFIX Orthofix Medical Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.